Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVE: To explore administrators' and clinicians' views on the factors that influence their use and adoption of a machine learning clinical decision support system (ML-CDSS) to predict patients' risk of hepatic and renal deterioration during chemotherapy. METHODS AND ANALYSIS: This was a qualitative study that used purposive sampling. 18 participants with administration and clinical background...
BACKGROUND: Identifying significant liver fibrosis (≥F2) is critical for initiating antiviral therapy in chronic hepatitis B (CHB). Chitinase-3-like protein 1 (CHI3L1) is a promising fibrosis biomarker, but its staging value remains unclear. We evaluated CHI3L1 (chemiluminescent immunoassay, CLIA) alone and with machine learning (ML) for differentiating mild (F0-F1) from significant (F2-F4) fibros...
INTRODUCTION: Current CALR mutation screening in myeloproliferative neoplasms (MPNs) faces a trade-off between coverage and cost: allele-specific qPCR...
We introduce Longitudinal-CT, a publicly available resource of whole-body computed tomography (CT) studies with exhaustive expert manual annotations o...
Neoadjuvant chemotherapy is a standard clinical practice for tumor downsizing in breast cancer, with [Formula: see text]F-FDG Positron Emission Tomogr...
Endometrial carcinoma (EC) incidence is increasing, with diabetes mellitus (DM) elevating EC risk. This study investigates the glycometabolism-associa...
Bufalin, a main active monomer component extracted from the Traditional Chinese Medicine toad venom, exhibits potent anti-tumour activity across diver...
There are large variations in how individual patients respond to allergen immunotherapy (AIT) against grass and/or birch allergy. There are currently ...
PURPOSE: This study aims to evaluate two advanced reasoning LLMs in generating treatment recommendations for real-world gastrointestinal stromal tumor...
Hepatitis B virus (HBV) infection can lead to hepatocellular carcinoma, and HBV integration into the host genome is regularly observed in the liver of...
BACKGROUND: The non-invasive detection of cancer via exhaled breath condensate (EBC) represents a promising frontier in oncology. This study explores ...
Accurate brain tumor segmentation by multi-modal MRI is crucial for diagnosis, treatment planning, and prognostic assessment. This work proposes a nov...
WEE1 kinase represents a promising therapeutic target in oncology due to its critical role in cell cycle checkpoint regulation. Traditional drug disco...
BACKGROUND: Selective internal radiation therapy (SIRT) increasingly relies on accurate magnetic resonance imaging (MRI) to computed tomography (CT) r...
Gastric cardia cancer (GCC) is an aggressive malignancy with poor prognosis, underscoring the need for better characterization of molecular alteration...
Whole-body bone scintigraphy is pivotal for skeletal evaluation in oncological monitoring, yet the unstructured nature of clinical reports impedes eff...
Dendrobine exhibits notable anti-tumor activity against breast cancer (BRCA). In this study, we integrated network pharmacology, bioinformatics, and e...
BACKGROUND: Breast cancer is the most common malignancy in women and includes molecular subtypes with distinct clinical outcomes, such as luminal A an...
Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis due to treatment resistance and an immunosuppressive, fibrotic microenvironment. Ferrop...
PURPOSE: To investigate the feasibility of non-invasively identifying bone marrow involvement (BMI) in follicular lymphoma (FL) using baseline 18F-FDG...